Size of FLT3 internal tandem duplication has prognostic significance in patients with acute myeloid leukemia

Derek L. Stirewalt, Kenneth J. Kopecky, Soheil Meshinchi, Julia H. Engel, Era L. Pogosova-Agadjanyan, Jeremy Linsley, Marilyn L. Slovak, Cheryl L. Willman, Jerald P. Radich

Research output: Contribution to journalArticlepeer-review

Abstract

FLT3 internal tandem duplications (FLT3/ITDs) in the juxtamembrane domain are found in approximately 25% of acute myeloid leukemia (AML) patients, ranging in size from 3 to hundreds of nucleotides. We examined whether the sizes of FLT3/ITDs were associated with clinical outcomes in 151 AML patients enrolled in Southwest Oncology Group studies: S9333 and S9500. FLT3/ITDs were identified in 32% of patients (median ITD size = 39 nucleotides; range, 15-153 nucleotides). The CR rates were 35%, 67%, and 52% for patients with large (≥ 40), small (< 40), and no ITDs, respectively (P = .19). Increasing ITD size was associated with decreasing OS (estimated 5-year OS: large = 13%, small = 26%, and no ITD = 21%, P = .072) and RFS (estimated 5-year RFS: large = 13%, small = 27%, and no ITD = 34%, P = .017). These studies suggest that ITD size may have prognostic significance.

Original languageEnglish (US)
Pages (from-to)3724-3726
Number of pages3
JournalBlood
Volume107
Issue number9
DOIs
StatePublished - May 1 2006

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Fingerprint

Dive into the research topics of 'Size of FLT3 internal tandem duplication has prognostic significance in patients with acute myeloid leukemia'. Together they form a unique fingerprint.

Cite this